OR WAIT null SECS
The HCPLive bipolar disorder page is a resource for medical news and expert insights on BPD. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for bipolar disease, and more.
December 31, 2022
Article
A new cross-sectional analysis suggest there are few options available for patients with schizophrenia or a serious mood disorder.
December 22, 2022
There was a decrease in relapse observed for low-risk participants, but not high-risk individuals.
August 13, 2022
Video
There remains a need for better treatments for bipolar disorder when it is identified early.
May 11, 2022
At Pri-Med West, primary care providers ask Dr. Michael Ziffra and Dr. Shirah Vollmer all the questions they have about treating mental illness and prescribing different classes of drugs.
May 10, 2022
Dr. Michael Ziffra talked during Pri-Med West 2022 about some of the challenges and gaps in research needed for better bipolar disorder care.
April 06, 2022
The treatment represents the only FDA approved orally dissolving sublingual film for this patient population.
March 11, 2022
Clinical decision support intervention resulted in a rate of change in total modifiable CV risk that was 4% lower among intervention patients compared to control.
December 20, 2021
The treatment is approved as either a monotherapy or an adjunctive therapy with either lithium or valproate.
December 06, 2021
Circadian disruption presented across a variety of high-risk, prodromal, and syndromic psychiatric disorders.
August 03, 2021
Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.